Amlodipine Besylate; Celecoxib Patent Expiration
Amlodipine Besylate; Celecoxib is Used for treating adult patients with hypertension and osteoarthritis. It was first introduced by Purple Biotech Ltd
Amlodipine Besylate; Celecoxib Patents
Given below is the list of patents protecting Amlodipine Besylate; Celecoxib, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Consensi | US10350171 | Celecoxib and amlodipine formulation and method of making the same | Jun 14, 2038 | Purple Biotech |
| Consensi | US10925835 | Celecoxib and amlodipine formulation and method of making the same | Jun 14, 2038 | Purple Biotech |
| Consensi | US10945960 | Celecoxib and amlodipine formulation and method of making the same | Jun 14, 2038 | Purple Biotech |
| Consensi | US9408837 | Ameliorating drug-induced elevations in blood pressure by adjunctive use of antihypertensive drugs | Feb 28, 2030 | Purple Biotech |
| Consensi | US9662315 | Ameliorating drug-induced elevations in blood pressure by adjunctive use of antihypertensive drugs | May 22, 2029 | Purple Biotech |
Amlodipine Besylate; Celecoxib's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List